ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Self-amplifying RNA (saRNA) Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-6S16968
Home | Market Reports | Science| Biological Sciences
Global Self amplifying RNA saRNA Drugs Market Research Report 2024
BUY CHAPTERS

Global Self-amplifying RNA (saRNA) Drugs Market Research Report 2025

Code: QYRE-Auto-6S16968
Report
September 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aldevron
Precision Nanosystems
CSL Limited
Arcturus Therapeutics
Chimeron Bio
Ziphius Vaccines
VaxEquity
Replicate Bioscience
Elixirgen Therapeutics
Immorna

Self-amplifying RNA (saRNA) Drugs Market

The global market for Self-amplifying RNA (saRNA) Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
saRNA is an RNA that shares many structural similarities with mRNA: it is a linear, single-stranded RNA molecule synthesized from a 5" cap, a 3" poly(A) tail, and 5" and 3" UTRs. The main difference is that saRNA is a larger molecule because it encodes four additional proteins in addition to the vaccine antigen or gene of interest. These four additional proteins are nonstructural proteins, usually derived from alphaviruses, encoding replicase enzymes. This replicase is able to amplify the original RNA strand upon delivery to cells, resulting in higher amounts of protein expression with minimal RNA dosage required.
North American market for Self-amplifying RNA (saRNA) Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Self-amplifying RNA (saRNA) Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Self-amplifying RNA (saRNA) Drugs include Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, Replicate Bioscience, Elixirgen Therapeutics, Immorna, CSL, Arcturus Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Self-amplifying RNA (saRNA) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Self-amplifying RNA (saRNA) Drugs.
The Self-amplifying RNA (saRNA) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Self-amplifying RNA (saRNA) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Self-amplifying RNA (saRNA) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Self-amplifying RNA (saRNA) Drugs Market Report

Report Metric Details
Report Name Self-amplifying RNA (saRNA) Drugs Market
Segment by Type
  • Preventive Medicine
  • Medicine
Segment by Application
  • Infectious Disease
  • Cancer
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, Replicate Bioscience, Elixirgen Therapeutics, Immorna, CSL, Arcturus Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Self-amplifying RNA (saRNA) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Self-amplifying RNA (saRNA) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Self-amplifying RNA (saRNA) Drugs Market report?

Ans: The main players in the Self-amplifying RNA (saRNA) Drugs Market are Chimeron Bio, Ziphius Vaccines, Aldevron, VaxEquity, Precision Nanosystems, Replicate Bioscience, Elixirgen Therapeutics, Immorna, CSL, Arcturus Therapeutics

What are the Application segmentation covered in the Self-amplifying RNA (saRNA) Drugs Market report?

Ans: The Applications covered in the Self-amplifying RNA (saRNA) Drugs Market report are Infectious Disease, Cancer, Others

What are the Type segmentation covered in the Self-amplifying RNA (saRNA) Drugs Market report?

Ans: The Types covered in the Self-amplifying RNA (saRNA) Drugs Market report are Preventive Medicine, Medicine

1 Self-amplifying RNA (saRNA) Drugs Market Overview
1.1 Product Definition
1.2 Self-amplifying RNA (saRNA) Drugs by Type
1.2.1 Global Self-amplifying RNA (saRNA) Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Preventive Medicine
1.2.3 Medicine
1.3 Self-amplifying RNA (saRNA) Drugs by Application
1.3.1 Global Self-amplifying RNA (saRNA) Drugs Market Value by Application (2024 VS 2031)
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Global Self-amplifying RNA (saRNA) Drugs Market Size Estimates and Forecasts
1.4.1 Global Self-amplifying RNA (saRNA) Drugs Revenue 2020-2031
1.4.2 Global Self-amplifying RNA (saRNA) Drugs Sales 2020-2031
1.4.3 Global Self-amplifying RNA (saRNA) Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Self-amplifying RNA (saRNA) Drugs Market Competition by Manufacturers
2.1 Global Self-amplifying RNA (saRNA) Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Self-amplifying RNA (saRNA) Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Self-amplifying RNA (saRNA) Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Self-amplifying RNA (saRNA) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Self-amplifying RNA (saRNA) Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Self-amplifying RNA (saRNA) Drugs, Product Type & Application
2.7 Global Key Manufacturers of Self-amplifying RNA (saRNA) Drugs, Date of Enter into This Industry
2.8 Global Self-amplifying RNA (saRNA) Drugs Market Competitive Situation and Trends
2.8.1 Global Self-amplifying RNA (saRNA) Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Self-amplifying RNA (saRNA) Drugs Players Market Share by Revenue
2.8.3 Global Self-amplifying RNA (saRNA) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Self-amplifying RNA (saRNA) Drugs Market Scenario by Region
3.1 Global Self-amplifying RNA (saRNA) Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Self-amplifying RNA (saRNA) Drugs Sales by Region: 2020-2031
3.2.1 Global Self-amplifying RNA (saRNA) Drugs Sales by Region: 2020-2025
3.2.2 Global Self-amplifying RNA (saRNA) Drugs Sales by Region: 2026-2031
3.3 Global Self-amplifying RNA (saRNA) Drugs Revenue by Region: 2020-2031
3.3.1 Global Self-amplifying RNA (saRNA) Drugs Revenue by Region: 2020-2025
3.3.2 Global Self-amplifying RNA (saRNA) Drugs Revenue by Region: 2026-2031
3.4 North America Self-amplifying RNA (saRNA) Drugs Market Facts & Figures by Country
3.4.1 North America Self-amplifying RNA (saRNA) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Self-amplifying RNA (saRNA) Drugs Sales by Country (2020-2031)
3.4.3 North America Self-amplifying RNA (saRNA) Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Self-amplifying RNA (saRNA) Drugs Market Facts & Figures by Country
3.5.1 Europe Self-amplifying RNA (saRNA) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Self-amplifying RNA (saRNA) Drugs Sales by Country (2020-2031)
3.5.3 Europe Self-amplifying RNA (saRNA) Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Self-amplifying RNA (saRNA) Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Self-amplifying RNA (saRNA) Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Self-amplifying RNA (saRNA) Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Self-amplifying RNA (saRNA) Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Self-amplifying RNA (saRNA) Drugs Market Facts & Figures by Country
3.7.1 Latin America Self-amplifying RNA (saRNA) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Self-amplifying RNA (saRNA) Drugs Sales by Country (2020-2031)
3.7.3 Latin America Self-amplifying RNA (saRNA) Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Self-amplifying RNA (saRNA) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Self-amplifying RNA (saRNA) Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Self-amplifying RNA (saRNA) Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Self-amplifying RNA (saRNA) Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Self-amplifying RNA (saRNA) Drugs Sales by Type (2020-2031)
4.1.1 Global Self-amplifying RNA (saRNA) Drugs Sales by Type (2020-2025)
4.1.2 Global Self-amplifying RNA (saRNA) Drugs Sales by Type (2026-2031)
4.1.3 Global Self-amplifying RNA (saRNA) Drugs Sales Market Share by Type (2020-2031)
4.2 Global Self-amplifying RNA (saRNA) Drugs Revenue by Type (2020-2031)
4.2.1 Global Self-amplifying RNA (saRNA) Drugs Revenue by Type (2020-2025)
4.2.2 Global Self-amplifying RNA (saRNA) Drugs Revenue by Type (2026-2031)
4.2.3 Global Self-amplifying RNA (saRNA) Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Self-amplifying RNA (saRNA) Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Self-amplifying RNA (saRNA) Drugs Sales by Application (2020-2031)
5.1.1 Global Self-amplifying RNA (saRNA) Drugs Sales by Application (2020-2025)
5.1.2 Global Self-amplifying RNA (saRNA) Drugs Sales by Application (2026-2031)
5.1.3 Global Self-amplifying RNA (saRNA) Drugs Sales Market Share by Application (2020-2031)
5.2 Global Self-amplifying RNA (saRNA) Drugs Revenue by Application (2020-2031)
5.2.1 Global Self-amplifying RNA (saRNA) Drugs Revenue by Application (2020-2025)
5.2.2 Global Self-amplifying RNA (saRNA) Drugs Revenue by Application (2026-2031)
5.2.3 Global Self-amplifying RNA (saRNA) Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Self-amplifying RNA (saRNA) Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Chimeron Bio
6.1.1 Chimeron Bio Company Information
6.1.2 Chimeron Bio Description and Business Overview
6.1.3 Chimeron Bio Self-amplifying RNA (saRNA) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Chimeron Bio Self-amplifying RNA (saRNA) Drugs Product Portfolio
6.1.5 Chimeron Bio Recent Developments/Updates
6.2 Ziphius Vaccines
6.2.1 Ziphius Vaccines Company Information
6.2.2 Ziphius Vaccines Description and Business Overview
6.2.3 Ziphius Vaccines Self-amplifying RNA (saRNA) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ziphius Vaccines Self-amplifying RNA (saRNA) Drugs Product Portfolio
6.2.5 Ziphius Vaccines Recent Developments/Updates
6.3 Aldevron
6.3.1 Aldevron Company Information
6.3.2 Aldevron Description and Business Overview
6.3.3 Aldevron Self-amplifying RNA (saRNA) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aldevron Self-amplifying RNA (saRNA) Drugs Product Portfolio
6.3.5 Aldevron Recent Developments/Updates
6.4 VaxEquity
6.4.1 VaxEquity Company Information
6.4.2 VaxEquity Description and Business Overview
6.4.3 VaxEquity Self-amplifying RNA (saRNA) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 VaxEquity Self-amplifying RNA (saRNA) Drugs Product Portfolio
6.4.5 VaxEquity Recent Developments/Updates
6.5 Precision Nanosystems
6.5.1 Precision Nanosystems Company Information
6.5.2 Precision Nanosystems Description and Business Overview
6.5.3 Precision Nanosystems Self-amplifying RNA (saRNA) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Precision Nanosystems Self-amplifying RNA (saRNA) Drugs Product Portfolio
6.5.5 Precision Nanosystems Recent Developments/Updates
6.6 Replicate Bioscience
6.6.1 Replicate Bioscience Company Information
6.6.2 Replicate Bioscience Description and Business Overview
6.6.3 Replicate Bioscience Self-amplifying RNA (saRNA) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Replicate Bioscience Self-amplifying RNA (saRNA) Drugs Product Portfolio
6.6.5 Replicate Bioscience Recent Developments/Updates
6.7 Elixirgen Therapeutics
6.7.1 Elixirgen Therapeutics Company Information
6.7.2 Elixirgen Therapeutics Description and Business Overview
6.7.3 Elixirgen Therapeutics Self-amplifying RNA (saRNA) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Elixirgen Therapeutics Self-amplifying RNA (saRNA) Drugs Product Portfolio
6.7.5 Elixirgen Therapeutics Recent Developments/Updates
6.8 Immorna
6.8.1 Immorna Company Information
6.8.2 Immorna Description and Business Overview
6.8.3 Immorna Self-amplifying RNA (saRNA) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Immorna Self-amplifying RNA (saRNA) Drugs Product Portfolio
6.8.5 Immorna Recent Developments/Updates
6.9 CSL
6.9.1 CSL Company Information
6.9.2 CSL Description and Business Overview
6.9.3 CSL Self-amplifying RNA (saRNA) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 CSL Self-amplifying RNA (saRNA) Drugs Product Portfolio
6.9.5 CSL Recent Developments/Updates
6.10 Arcturus Therapeutics
6.10.1 Arcturus Therapeutics Company Information
6.10.2 Arcturus Therapeutics Description and Business Overview
6.10.3 Arcturus Therapeutics Self-amplifying RNA (saRNA) Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Arcturus Therapeutics Self-amplifying RNA (saRNA) Drugs Product Portfolio
6.10.5 Arcturus Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Self-amplifying RNA (saRNA) Drugs Industry Chain Analysis
7.2 Self-amplifying RNA (saRNA) Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Self-amplifying RNA (saRNA) Drugs Production Mode & Process Analysis
7.4 Self-amplifying RNA (saRNA) Drugs Sales and Marketing
7.4.1 Self-amplifying RNA (saRNA) Drugs Sales Channels
7.4.2 Self-amplifying RNA (saRNA) Drugs Distributors
7.5 Self-amplifying RNA (saRNA) Drugs Customer Analysis
8 Self-amplifying RNA (saRNA) Drugs Market Dynamics
8.1 Self-amplifying RNA (saRNA) Drugs Industry Trends
8.2 Self-amplifying RNA (saRNA) Drugs Market Drivers
8.3 Self-amplifying RNA (saRNA) Drugs Market Challenges
8.4 Self-amplifying RNA (saRNA) Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Aldevron
Precision Nanosystems
CSL Limited
Arcturus Therapeutics
Chimeron Bio
Ziphius Vaccines
VaxEquity
Replicate Bioscience
Elixirgen Therapeutics
Immorna
List of Tables
 Table 1. Global Self-amplifying RNA (saRNA) Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Self-amplifying RNA (saRNA) Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Self-amplifying RNA (saRNA) Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Self-amplifying RNA (saRNA) Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Self-amplifying RNA (saRNA) Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Self-amplifying RNA (saRNA) Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Self-amplifying RNA (saRNA) Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Self-amplifying RNA (saRNA) Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Self-amplifying RNA (saRNA) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Self-amplifying RNA (saRNA) Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Self-amplifying RNA (saRNA) Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Self-amplifying RNA (saRNA) Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Self-amplifying RNA (saRNA) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Self-amplifying RNA (saRNA) Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Self-amplifying RNA (saRNA) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Self-amplifying RNA (saRNA) Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Self-amplifying RNA (saRNA) Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Self-amplifying RNA (saRNA) Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Self-amplifying RNA (saRNA) Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Self-amplifying RNA (saRNA) Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Self-amplifying RNA (saRNA) Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Self-amplifying RNA (saRNA) Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Self-amplifying RNA (saRNA) Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Self-amplifying RNA (saRNA) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Self-amplifying RNA (saRNA) Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Self-amplifying RNA (saRNA) Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Self-amplifying RNA (saRNA) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Self-amplifying RNA (saRNA) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Self-amplifying RNA (saRNA) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Self-amplifying RNA (saRNA) Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Self-amplifying RNA (saRNA) Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Self-amplifying RNA (saRNA) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Self-amplifying RNA (saRNA) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Self-amplifying RNA (saRNA) Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Self-amplifying RNA (saRNA) Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Self-amplifying RNA (saRNA) Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Self-amplifying RNA (saRNA) Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Self-amplifying RNA (saRNA) Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Self-amplifying RNA (saRNA) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Self-amplifying RNA (saRNA) Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Self-amplifying RNA (saRNA) Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Self-amplifying RNA (saRNA) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Self-amplifying RNA (saRNA) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Self-amplifying RNA (saRNA) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Self-amplifying RNA (saRNA) Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Self-amplifying RNA (saRNA) Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Self-amplifying RNA (saRNA) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Self-amplifying RNA (saRNA) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Self-amplifying RNA (saRNA) Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Self-amplifying RNA (saRNA) Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Self-amplifying RNA (saRNA) Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Self-amplifying RNA (saRNA) Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Self-amplifying RNA (saRNA) Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Self-amplifying RNA (saRNA) Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Self-amplifying RNA (saRNA) Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Self-amplifying RNA (saRNA) Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Self-amplifying RNA (saRNA) Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Self-amplifying RNA (saRNA) Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Self-amplifying RNA (saRNA) Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Self-amplifying RNA (saRNA) Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Self-amplifying RNA (saRNA) Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Self-amplifying RNA (saRNA) Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Self-amplifying RNA (saRNA) Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Self-amplifying RNA (saRNA) Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Self-amplifying RNA (saRNA) Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Self-amplifying RNA (saRNA) Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Self-amplifying RNA (saRNA) Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Self-amplifying RNA (saRNA) Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Chimeron Bio Company Information
 Table 71. Chimeron Bio Description and Business Overview
 Table 72. Chimeron Bio Self-amplifying RNA (saRNA) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Chimeron Bio Self-amplifying RNA (saRNA) Drugs Product
 Table 74. Chimeron Bio Recent Developments/Updates
 Table 75. Ziphius Vaccines Company Information
 Table 76. Ziphius Vaccines Description and Business Overview
 Table 77. Ziphius Vaccines Self-amplifying RNA (saRNA) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Ziphius Vaccines Self-amplifying RNA (saRNA) Drugs Product
 Table 79. Ziphius Vaccines Recent Developments/Updates
 Table 80. Aldevron Company Information
 Table 81. Aldevron Description and Business Overview
 Table 82. Aldevron Self-amplifying RNA (saRNA) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Aldevron Self-amplifying RNA (saRNA) Drugs Product
 Table 84. Aldevron Recent Developments/Updates
 Table 85. VaxEquity Company Information
 Table 86. VaxEquity Description and Business Overview
 Table 87. VaxEquity Self-amplifying RNA (saRNA) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. VaxEquity Self-amplifying RNA (saRNA) Drugs Product
 Table 89. VaxEquity Recent Developments/Updates
 Table 90. Precision Nanosystems Company Information
 Table 91. Precision Nanosystems Description and Business Overview
 Table 92. Precision Nanosystems Self-amplifying RNA (saRNA) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Precision Nanosystems Self-amplifying RNA (saRNA) Drugs Product
 Table 94. Precision Nanosystems Recent Developments/Updates
 Table 95. Replicate Bioscience Company Information
 Table 96. Replicate Bioscience Description and Business Overview
 Table 97. Replicate Bioscience Self-amplifying RNA (saRNA) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Replicate Bioscience Self-amplifying RNA (saRNA) Drugs Product
 Table 99. Replicate Bioscience Recent Developments/Updates
 Table 100. Elixirgen Therapeutics Company Information
 Table 101. Elixirgen Therapeutics Description and Business Overview
 Table 102. Elixirgen Therapeutics Self-amplifying RNA (saRNA) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Elixirgen Therapeutics Self-amplifying RNA (saRNA) Drugs Product
 Table 104. Elixirgen Therapeutics Recent Developments/Updates
 Table 105. Immorna Company Information
 Table 106. Immorna Description and Business Overview
 Table 107. Immorna Self-amplifying RNA (saRNA) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Immorna Self-amplifying RNA (saRNA) Drugs Product
 Table 109. Immorna Recent Developments/Updates
 Table 110. CSL Company Information
 Table 111. CSL Description and Business Overview
 Table 112. CSL Self-amplifying RNA (saRNA) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. CSL Self-amplifying RNA (saRNA) Drugs Product
 Table 114. CSL Recent Developments/Updates
 Table 115. Arcturus Therapeutics Company Information
 Table 116. Arcturus Therapeutics Description and Business Overview
 Table 117. Arcturus Therapeutics Self-amplifying RNA (saRNA) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Arcturus Therapeutics Self-amplifying RNA (saRNA) Drugs Product
 Table 119. Arcturus Therapeutics Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Self-amplifying RNA (saRNA) Drugs Distributors List
 Table 123. Self-amplifying RNA (saRNA) Drugs Customers List
 Table 124. Self-amplifying RNA (saRNA) Drugs Market Trends
 Table 125. Self-amplifying RNA (saRNA) Drugs Market Drivers
 Table 126. Self-amplifying RNA (saRNA) Drugs Market Challenges
 Table 127. Self-amplifying RNA (saRNA) Drugs Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Self-amplifying RNA (saRNA) Drugs
 Figure 2. Global Self-amplifying RNA (saRNA) Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Self-amplifying RNA (saRNA) Drugs Market Share by Type: 2024 & 2031
 Figure 4. Preventive Medicine Product Picture
 Figure 5. Medicine Product Picture
 Figure 6. Global Self-amplifying RNA (saRNA) Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Self-amplifying RNA (saRNA) Drugs Market Share by Application: 2024 & 2031
 Figure 8. Infectious Disease
 Figure 9. Cancer
 Figure 10. Others
 Figure 11. Global Self-amplifying RNA (saRNA) Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Self-amplifying RNA (saRNA) Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Self-amplifying RNA (saRNA) Drugs Sales (2020-2031) & (K Units)
 Figure 14. Global Self-amplifying RNA (saRNA) Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 15. Self-amplifying RNA (saRNA) Drugs Report Years Considered
 Figure 16. Self-amplifying RNA (saRNA) Drugs Sales Share by Manufacturers in 2024
 Figure 17. Global Self-amplifying RNA (saRNA) Drugs Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Self-amplifying RNA (saRNA) Drugs Players: Market Share by Revenue in Self-amplifying RNA (saRNA) Drugs in 2024
 Figure 19. Self-amplifying RNA (saRNA) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Self-amplifying RNA (saRNA) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Self-amplifying RNA (saRNA) Drugs Sales Market Share by Country (2020-2031)
 Figure 22. North America Self-amplifying RNA (saRNA) Drugs Revenue Market Share by Country (2020-2031)
 Figure 23. United States Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Self-amplifying RNA (saRNA) Drugs Sales Market Share by Country (2020-2031)
 Figure 26. Europe Self-amplifying RNA (saRNA) Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Self-amplifying RNA (saRNA) Drugs Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Self-amplifying RNA (saRNA) Drugs Revenue Market Share by Region (2020-2031)
 Figure 34. China Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Self-amplifying RNA (saRNA) Drugs Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Self-amplifying RNA (saRNA) Drugs Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Self-amplifying RNA (saRNA) Drugs Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Self-amplifying RNA (saRNA) Drugs Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Self-amplifying RNA (saRNA) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Self-amplifying RNA (saRNA) Drugs by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Self-amplifying RNA (saRNA) Drugs by Type (2020-2031)
 Figure 53. Global Self-amplifying RNA (saRNA) Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Self-amplifying RNA (saRNA) Drugs by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Self-amplifying RNA (saRNA) Drugs by Application (2020-2031)
 Figure 56. Global Self-amplifying RNA (saRNA) Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 57. Self-amplifying RNA (saRNA) Drugs Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Self Amplifying RNA In Vitro Synthesis Service Market Research Report 2025
Global saRNA Synthesis Service Market Research Report 2025
Global Self replicating mRNA Vaccines Market Research Report 2024
mRNA Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global RNA Vaccines Market Insights Forecast to 2030
Global ircular RNA Synthesis Service Market Research Report 2024
Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Single stranded Nucleic Acid Synthesizer Market Research Report 2024
Global RNA Synthesis Market Research Report 2024
Global mRNA Vaccines Therapeutics Market Research Report 2024
Global Circular RNA Research Market Insights Forecast to 2030
Global mRNA Synthesis Manufacturing Market Research Report 2024
mRNA COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Small Interfering RNA siRNA Drugs Market Research Report 2024
Global Nucleic Acid Vaccine Market Insights Forecast to 2030
Global shRNA Clones Market Research Report 2025
mRNA Transcriptome Sequencing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nucleic Vaccine Market Insights Forecast to 2030
Global Small Interfering RNA siRNA based Therapeutics Market Research Report 2024
Global In Vitro Transcription RNA Synthesis Service Market Research Report 2025

RELATED REPORTS

Global Cell-free DNA Testing Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B20127
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global cfDNA Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36H20013
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Strong Cation Exchange Agarose Gel Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7C20305
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Deoxyadenosine Triphosphate Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13N20234
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions